Cargando…

Tumor microenvironment characterization in head and neck squamous carcinoma reveals distinct genomic alterations and clinical outcomes

Detalles Bibliográficos
Autores principales:	Shi, Run, Bao, Xuanwen, Sun, Jing, Lu, Shun, Belka, Claus, Li, Minglun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520081/ https://www.ncbi.nlm.nih.gov/pubmed/32997410 http://dx.doi.org/10.1002/ctm2.187

Ejemplares similares

Identification and validation of hypoxia-derived gene signatures to predict clinical outcomes and therapeutic responses in stage I lung adenocarcinoma patients
por: Shi, Run, et al.
Publicado: (2021)

Characterization of immune landscape in papillary thyroid cancer reveals distinct tumor immunogenicity and implications for immunotherapy
por: Sun, Jing, et al.
Publicado: (2021)

Cell cycle progression score as a predictive biomarker for overall survival in patients with adrenocortical carcinoma
por: Sun, Jing, et al.
Publicado: (2020)

Establishment and Validation of an Individualized Cell Cycle Process-Related Gene Signature to Predict Cancer-Specific Survival in Patients with Bladder Cancer
por: Shi, Run, et al.
Publicado: (2020)

TNF Patterns and Tumor Microenvironment Characterization in Head and Neck Squamous Cell Carcinoma
por: Long, Qian, et al.
Publicado: (2021)

The Immune Microenvironment in Head and Neck Squamous Cell Carcinoma: on Subsets and Subsites
por: Wondergem, Niels E., et al.
Publicado: (2020)

Immunogenomic alterations of head and neck squamous cell carcinomas stratified by smoking status
por: Huang, Yixuan, et al.
Publicado: (2021)

Excellent local control and survival after postoperative or definitive radiation therapy for sarcomas of the head and neck
por: Andrä, Claudia, et al.
Publicado: (2015)

Characterization of Molecular Subtypes in Head and Neck Squamous Cell Carcinoma With Distinct Prognosis and Treatment Responsiveness
por: Zhang, Pei, et al.
Publicado: (2021)

Understanding the tumor microenvironment in head and neck squamous cell carcinoma
por: Rad, Habib Sadeghi, et al.
Publicado: (2022)

Targeted therapy for head and neck squamous cell carcinoma microenvironment
por: Guo, Zhaomeng, et al.
Publicado: (2023)

Pyroptosis-Related Signature and Tumor Microenvironment Infiltration Characterization in Head and Neck Squamous Cell Carcinoma
por: Wu, Zeng-Hong, et al.
Publicado: (2022)

The Prognostic Value of TP53 Alteration in Patients with Head and Neck Squamous Cell Carcinoma Receiving Immunotherapy
por: Jiang, Chao, et al.
Publicado: (2022)

A Novel Gene Signature-Based Model Predicts Biochemical Recurrence-Free Survival in Prostate Cancer Patients after Radical Prostatectomy
por: Shi, Run, et al.
Publicado: (2019)

Rabbit VX2 head and neck squamous cell models for translational head and neck theranostic technology development
por: Muhanna, Nidal, et al.
Publicado: (2021)

Targeting the Immune Microenvironment in the Treatment of Head and Neck Squamous Cell Carcinoma
por: Wang, Hui-Ching, et al.
Publicado: (2019)

Tumor microenvironment and immune evasion in head and neck squamous cell carcinoma
por: Elmusrati, Areeg, et al.
Publicado: (2021)

Methylation related genes are associated with prognosis of patients with head and neck squamous cell carcinoma via altering tumor immune microenvironment
por: Tian, Xudong, et al.
Publicado: (2023)

Comprehensive characterization of the tumor microenvironment for assessing immunotherapy outcome in patients with head and neck squamous cell carcinoma
por: Zhang, Jian, et al.
Publicado: (2020)

Identification of cuproptosis‐related subtypes and characterization of the tumor microenvironment landscape in head and neck squamous cell carcinoma
por: Huang, Juntao, et al.
Publicado: (2022)

Comprehensive characterization of the alternative splicing landscape in head and neck squamous cell carcinoma reveals novel events associated with tumorigenesis and the immune microenvironment
por: Li, Zhi-Xuan, et al.
Publicado: (2019)

Microenvironmental genomic alterations reveal signaling networks for head and neck squamous cell carcinoma
por: Bebek, Gurkan, et al.
Publicado: (2011)

Definitive chemoradiotherapy in patients with squamous cell cancers of the head and neck - results from an unselected cohort of the clinical cooperation group “Personalized Radiotherapy in Head and Neck Cancer”
por: Schüttrumpf, Lars, et al.
Publicado: (2020)

The Aging-Related Prognostic Signature Reveals the Landscape of the Tumor Immune Microenvironment in Head and Neck Squamous Cell Carcinoma
por: Chen, Fang, et al.
Publicado: (2022)

Metformin effects on head and neck squamous carcinoma microenvironment: Window of opportunity trial
por: Curry, Joseph, et al.
Publicado: (2017)

Influence of Immune Microenvironment on Diagnosis and Prognosis of Head and Neck Squamous Cell Carcinoma
por: Liu, Guohong, et al.
Publicado: (2021)

Tumor microenvironment and immune-related therapies of head and neck squamous cell carcinoma
por: Qin, Yixiao, et al.
Publicado: (2021)

The role of nanotherapy in head and neck squamous cell carcinoma by targeting tumor microenvironment
por: Zhang, Ye, et al.
Publicado: (2023)

Prognosis and Characterization of Immune Microenvironment in Head and Neck Squamous Cell Carcinoma through a Pyroptosis-Related Signature
por: Lu, Lin, et al.
Publicado: (2022)

No Evidence for FANCF Gene Silencing in Head-and-Neck Squamous Cell Carcinomas
por: Ameziane, Najim, et al.
Publicado: (2009)

Disproportional enrichment of FoxP3(+)CD4(+) regulatory T cells shapes a suppressive tumour microenvironment in head and neck squamous cell carcinoma
por: Park, Seyeon, et al.
Publicado: (2022)

In Reply: TP53 Alteration Status and Tumor Mutational Burden Score: Prevalence and Prognosis in Head and Neck Squamous Cell Carcinoma
por: Burcher, Kimberly M, et al.
Publicado: (2022)

Postoperative (chemo) radiation in patients with squamous cell cancers of the head and neck – clinical results from the cohort of the clinical cooperation group “Personalized Radiotherapy in Head and Neck Cancer”
por: Maihoefer, Cornelius, et al.
Publicado: (2018)

Alterations of GPI transamidase subunits in head and neck squamous carcinoma
por: Jiang, Wei-Wen, et al.
Publicado: (2007)

The role of PDGF in radiation oncology
por: Li, Minglun, et al.
Publicado: (2007)

The ProMotion LMU dataset, prostate intra-fraction motion recorded by transperineal ultrasound
por: Ballhausen, Hendrik, et al.
Publicado: (2019)

Multi-Omics Integration Reveals the Crucial Role of Fusobacterium in the Inflammatory Immune Microenvironment in Head and Neck Squamous Cell Carcinoma
por: Qiao, Han, et al.
Publicado: (2022)

Construction of the prognostic signature of alternative splicing revealed the prognostic predictor and immune microenvironment in head and neck squamous cell carcinoma
por: Ye, Fan, et al.
Publicado: (2022)

Immunotherapy for Head and Neck Squamous Cell Carcinoma
por: Moskovitz, Jessica, et al.
Publicado: (2018)

Radiochemotherapy in stage III/IV nonmetastatic squamous cell head and neck cancer
por: Schäfer, C, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_6l6bhbo1h5rfvn81s6l9d9hdm6